series-a
Stage
2021
Founded
2
Investors
About
Vessi Medical develops a patent-protected cryo spray system and disposable transurethral device for minimally invasive cryotherapy treatment of hollow and humid organs, primarily the bladder, aiming to provide a non-surgical alternative with fewer complications. The system entered first-in-human clinical trials in 2021 and is not yet commercially available.
Explore Vessi Medical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.